Objective: The purpose of this study was to quantify quit rates, determine factors predicting success, and analyze patients' perceptions at 3 months after participation in the pharmacist-managed Smoking Cessation Group Clinic.

Methods: This was a prospective, single group study that was conducted in patients that had participated in the Smoking Cessation Group Clinic at the University of Iowa Hospitals and Clinics. Clinic participants received structured group counseling covering various topics associated with cessation. Varenicline, bupropion and nicotine replacement therapy were used as smoking cessation aids and selection was based on patient preference and absence of contraindications. The primary outcome of this trial was smoking status at 3 months. The patients were contacted by telephone at 3, and 6 months after the start of the clinic and asked about current smoking status. At 3 months, patients were asked to rate on a Likert scale of 1 to 5 (1=not helpful; 5=very helpful) their perceptions of individual aspects of the clinic and on a scale of 1 to 10 (1=not helpful; 10=very helpful) how they perceived their cessation aid.

Results: From February 2007 to January 2008, 21 patients enrolled in the intent-to-treat follow up study. Analysis of data was completed in August 2008. At 3 and 6 months, 47.6% and 52.4%, of patients reported being smoke-free, respectively. At 3 months, factors consistent with success included having more previous quit attempts and type of cessation aid used. These endpoints continued to be significant at 6 months, in addition to attending more clinic sessions, and type of insurance (favoring private insurance). Patients who quit smoking rated their cessation aid as more helpful than those who did not quit smoking (8.56; SD=0.88 verses 6.71; SD=2.81, respectively; p=0.14). The aspect of the clinic most helpful to patients was group interaction (4.53; SD=0.77).

Conclusion: This study demonstrates that pharmacists can play a vital role with smoking cessation in a group setting. Group setting patient counseling can be an effective tool for pharmacists to reach more people within the same time frame as individual counseling.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139046PMC
http://dx.doi.org/10.4321/s1886-36552009000300004DOI Listing

Publication Analysis

Top Keywords

smoking cessation
20
cessation group
12
smoking
9
cessation
9
quit rates
8
smoking status
8
status months
8
months patients
8
scale 1=not
8
1=not helpful
8

Similar Publications

Lung cancer is the leading cause of cancer-related deaths worldwide, and delayed detection contributes to poor outcomes. Primary care plays a crucial role in early diagnosis, but detecting lung cancer early remains challenging for general practitioners (GPs). Therefore, the aim of this scoping review was to identify optimal strategies and pathways for lung cancer screening (LCS) in primary care settings globally.

View Article and Find Full Text PDF

The Connection Between Stress and Women's Smoking During the Perinatal Period: A Systematic Review.

Brain Sci

December 2024

Department of Clinical Psychology and Psychobiology, Faculty of Psychology, Institute of Psychology (IPsiUS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain.

Introduction: In women, smoking during pregnancy and the postpartum period has important consequences for maternal and infant health, and interventions to assist smoking cessation during this period are essential. Although smoking has been associated with the presence of mental health problems, few studies addressing the factors associated with perinatal smoking have examined the role of stress. The aim of this review was to identify the relationships between the presence of stress and smoking during pregnancy and the postpartum period.

View Article and Find Full Text PDF

Background: Previous research has identified differences in e-cigarette use and socioeconomic factors between different racial groups However, there is little research examining specific risk factors contributing to the racial differences.

Objective: This study sought to identify racial disparities in e-cigarette use and to determine risk factors that help explain these differences.

Methods: We used Wave 5 (2018-2019) of the Adult Population Assessment of Tobacco and Health (PATH) Study.

View Article and Find Full Text PDF

Implementation of stop smoking support by mental healthcare professionals: cross-sectional analysis of why nothing much happens.

Discov Ment Health

January 2025

Public Health and Primary Care, Leiden University Medical Center, Hippocratespad 21, PO Box 9600, 2300 RC, Leiden, The Netherlands.

Smoking is highly prevalent and persistent among people with mental illness, but implementation of smoking cessation care by mental healthcare professionals (MHCPs) is lagging behind. This study took a broad approach to understanding implementation of stop smoking support (SSS) by MHCPs (N = 220 for main analyses), incorporating background characteristics, psychosocial factors, client factors, and organizational/environmental factors. Variable selection was based on previous work and the Consolidated Framework for Implementation Research.

View Article and Find Full Text PDF

Aim: In February 2024, the Aotearoa New Zealand Government repealed legislation to mandate very low nicotine cigarettes (VLNCs), greatly reduce the number of tobacco retailers and disallow sale of tobacco products to people born after 2008 (smokefree generation). We investigated acceptability and likely impacts of these measures among people who smoke or who recently (≤2 years) quit smoking.

Method: We analysed data from 1,230 participants from Wave 3 (conducted in late 2020 and early 2021) and 615 participants from Wave 3.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!